Medifast, Inc. (0K05.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 117.17M |
| Enterprise Value | 44.65M |
| P/E Ratio | -3.49 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.48 |
| Price/Book Ratio | 0.8 |
| Enterprise/Revenue | 0.35 |
| Enterprise/EBITDA | -5.66 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.14 |
| Operating Margin | -0.11 |
AD
Management Effectiveness
| Return On Assets | -0.17 |
| Return On Equity | -0.21 |
Income Statement
| Revenue | 385.79M |
| Revenue/Share | 26.79 |
| Gross Profit | 275.19M |
| EBITDA | -3.71M |
| Net Income | -18.67M |
| Diluted EPS | -1.7 |
Balance Sheet
| Total Cash | 172.53M |
| Total Cash/Share | 15.43 |
| Total Debt | 20.69M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 4.82 |
| Book Value Per Share | 16.12 |
Price History
| 52-Week Change | 10.58 |
| 52-Week High | 13.54 |
| 52-Week Low | 9.27 |
| Moving Average 50 Days | 12.17 |
| Moving Average 200 Days | 11.41 |
Statistics
| Average Volume | 204 |
| Shares Outstanding | 11.18M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
